Baker Bros. Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78.2M | Buy |
|
|||||
|
2025
Q1 | $62.6M | Hold |
|
|||||
|
2024
Q4 | $55.7M | Hold |
|
|||||
|
2024
Q3 | $70.4M | Hold |
|
|||||
|
2024
Q2 | $52.6M | Buy |
|
|||||
|
2024
Q1 | $55.4M | Hold |
|
|||||
|
2023
Q4 | $49.3M | Hold |
|
|||||
|
2023
Q3 | $48.8M | Hold |
|
|||||
|
2023
Q2 | $39.6M | Buy |
|
|||||
|
2023
Q1 | $30.1M | Hold |
|
|||||
|
2022
Q4 | $41.9M | Hold |
|
|||||
|
2022
Q3 | $35.9M | Hold |
|
|||||
|
2022
Q2 | $27.1M | Hold |
|
|||||
|
2022
Q1 | $27.8M | Hold |
|
|||||
|
2021
Q4 | $33M | Hold |
|
|||||
|
2021
Q3 | $31.9M | Hold |
|
|||||
|
2021
Q2 | $39M | Hold |
|
|||||
|
2021
Q1 | $51.8M | Hold |
|
|||||
|
2020
Q4 | $49.5M | Hold |
|
|||||
|
2020
Q3 | $42.9M | Hold |
|
|||||
|
2020
Q2 | $71.3M | Hold |
|
|||||
|
2020
Q1 | $43.3M | Hold |
|
|||||
|
2019
Q4 | $31M | Hold |
|
|||||
|
2019
Q3 | $23.8M | Hold |
|
|||||
|
2019
Q2 | $37.9M | Sell |
|
|||||
|
2019
Q1 | $54.2M | Hold |
|
|||||
|
2018
Q4 | $84.3M | Hold |
|
|||||
|
2018
Q3 | $76.5M | Hold |
|
|||||
|
2018
Q2 | $52M | Buy |
|